BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3398071)

  • 1. Shift from polyploidizing to nonpolyploidizing growth in carcinogen-treated rat liver.
    Saeter G; Schwarze E; Seglen O
    J Natl Cancer Inst; 1988 Aug; 80(12):950-8. PubMed ID: 3398071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas.
    Saeter G; Schwarze PE; Nesland JM; Juul N; Pettersen EO; Seglen PO
    Carcinogenesis; 1988 Jun; 9(6):939-45. PubMed ID: 3370757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism.
    Saeter G; Schwarze PE; Nesland JM; Seglen PO
    Carcinogenesis; 1988 Apr; 9(4):581-7. PubMed ID: 2895691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation.
    Gerlyng P; Grotmol T; Seglen PO
    Carcinogenesis; 1994 Feb; 15(2):371-9. PubMed ID: 7508825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
    De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
    Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the tumor promoter 2-acetylaminofluorene and of 4-acetylaminofluorene on rat liver growth.
    Gerlyng P; Seglen PO
    Bull Cancer; 1990; 77(5):461-6. PubMed ID: 2400817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of a population of small, diploid hepatocytes during hepatocarcinogenesis.
    Schwarze PE; Pettersen EO; Shoaib MC; Seglen PO
    Carcinogenesis; 1984 Oct; 5(10):1267-75. PubMed ID: 6149024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation in carcinogen-induced diploid and polyploid hepatocytes separated by centrifugal elutriation.
    Watkins JB; Thierau D; Schwarz LR
    Cancer Res; 1992 Mar; 52(5):1149-54. PubMed ID: 1737374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic preneoplasia induction in male Wistar rats: histological studies up to five months post treatment.
    Pisani GB; Valenti JL; Quintana AB
    Rev Esp Enferm Dig; 2016 Aug; 108(8):457-63. PubMed ID: 27444315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells.
    Saeter G; Schwarze PE; Nesland JM; Seglen PO
    Br J Cancer; 1989 Feb; 59(2):198-205. PubMed ID: 2930686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone modifies the growth rate of enzyme-altered hepatic foci in male rats treated according to the resistant hepatocyte model.
    Blanck A; Hansson T; Eriksson LC; Gustafsson JA
    Carcinogenesis; 1987 Nov; 8(11):1585-8. PubMed ID: 3478155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-related alterations during liver carcinogenesis: effect of promoters.
    Seglen PO; Gerlyng P
    Environ Health Perspect; 1990 Aug; 88():197-205. PubMed ID: 2272315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of hepatocytes from carcinogen-treated rats by two-parametric flow cytometry.
    Schwarze PE; Pettersen EO; Seglen PO
    Carcinogenesis; 1986 Jan; 7(1):171-3. PubMed ID: 3943139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis.
    Garcea R; Daino L; Pascale R; Frassetto S; Cozzolino P; Ruggiu ME; Feo F
    Toxicol Pathol; 1987; 15(2):164-9. PubMed ID: 2956667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced proliferative activity of polyploid cells in primary hepatocellular carcinoma.
    Gerlyng P; Grotmol T; Erikstein B; Stokke T; Seglen PO
    Carcinogenesis; 1992 Oct; 13(10):1795-801. PubMed ID: 1330342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrifugal elutriation of hepatocytes from 2-acetylaminofluorene-treated rats and their characterization by flow cytometry.
    Klose U; Thierau D; Greim H; Schwarz LR
    Carcinogenesis; 1989 Mar; 10(3):553-6. PubMed ID: 2564321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to gamma-glutamyltranspeptidase-positive foci in male rat liver.
    Kroese ED; van de Poll ML; Mulder GJ; Meerman JH
    Carcinogenesis; 1988 Nov; 9(11):1953-8. PubMed ID: 2902938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cytological comparison between regeneration, hyperplasia and early neoplasia in the rat liver.
    Styles JA; Kelly M; Elcombe CR
    Carcinogenesis; 1987 Mar; 8(3):391-9. PubMed ID: 3815733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
    Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
    Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variations of S-adenosyl-L-methionine content modulate hepatocyte growth during phenobarbital promotion of diethylnitrosamine-induced rat liver carcinogenesis.
    Feo F; Garcea R; Pascale R; Pirisi L; Daino L; Donaera A
    Toxicol Pathol; 1987; 15(1):109-14. PubMed ID: 2883718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.